Skip to main content
Medical information Clinical review pending

Ophthalmology Testing

Ophthalmology Eyes Vision Panel Genetic Test

The Ophthalmology Eyes Vision Panel NGS Genetic DNA Test uses Next-Generation Sequencing (NGS) to identify genetic mutations linked to various eye disorders. This test is valuable for individuals with a family history of eye conditions or unexplained vision problems, aiding in early detection and management.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample, Extracted DNA, or One drop of blood on FTA card.
Results
Approximately 3 to 4 weeks. Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Ophthalmology Eyes Vision Panel Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals with unexplained vision loss or impairment.
  • ✓Patients with a family history of inherited eye disorders.
  • ✓Individuals experiencing symptoms suggestive of retinal dystrophies.
  • ✓Those with unexplained visual disturbances.
  • ✓Family planning for individuals with a known history of hereditary eye conditions.
02

In plain language

What this test helps you understand

This test helps identify genetic mutations associated with inherited eye disorders, enabling early diagnosis, personalized management strategies, and informed family planning.
The Ophthalmology Eyes Vision Panel NGS Genetic DNA Test is an advanced genetic diagnostic tool that utilizes Next-Generation Sequencing (NGS) technology to detect mutations associated with various ophthalmological disorders. This test is crucial for individuals who may be at risk of hereditary eye conditions, enabling timely intervention and management. Understanding your genetic predisposition to eye disorders can significantly impact your health management strategies. This test provides vital information that can guide treatment options and preventive measures, thereby improving patient outcomes. The test analyzes specific genes known to be associated with eye diseases, including ABCA4, ABCB6, ADGRV1, RPE65, and USH2A. Results from the test will indicate whether any genetic mutations were detected. It is essential to discuss these results with a qualified healthcare professional who can provide guidance on the implications of the findings and the next steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking.
SampleBlood sample, Extracted DNA, or One drop of blood on FTA card.
MethodologyNext-Generation Sequencing (NGS).
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes specific genes associated with eye disorders. It may not detect all possible genetic causes of vision problems. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test detects genetic mutations in specific genes known to be associated with various inherited eye disorders.
Individuals with unexplained vision loss, a family history of eye disorders, or symptoms of retinal dystrophies should consider this test.
A blood sample, extracted DNA, or a single drop of blood on an FTA card is required.
Results are typically available within 3 to 4 weeks. Confirm with the laboratory before booking.
It is essential to discuss your results with a qualified healthcare professional to understand their implications and plan next steps.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp